264 related articles for article (PubMed ID: 7998063)
1. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
[TBL] [Abstract][Full Text] [Related]
2. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
[TBL] [Abstract][Full Text] [Related]
3. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
Yazer MH; Podlosky L; Clarke G; Nahirniak SM
Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
[TBL] [Abstract][Full Text] [Related]
4. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
[TBL] [Abstract][Full Text] [Related]
5. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
Rajesh K; Harsh S; Amarjit K
Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
[TBL] [Abstract][Full Text] [Related]
6. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
[TBL] [Abstract][Full Text] [Related]
7. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
[TBL] [Abstract][Full Text] [Related]
8. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
[TBL] [Abstract][Full Text] [Related]
9. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
Wang RR; Triulzi DJ; Qu L
Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
[TBL] [Abstract][Full Text] [Related]
10. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of platelet transfusion.
Williamson LM
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):643-6. PubMed ID: 1333290
[TBL] [Abstract][Full Text] [Related]
12. Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components.
Singh L; Prinja N; Jain A; Sharma RR; Marwaha N
Asian J Transfus Sci; 2023; 17(1):69-73. PubMed ID: 37188007
[TBL] [Abstract][Full Text] [Related]
13. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.
Cohen R; Escorcia A; Tasmin F; Lima A; Lin Y; Lieberman L; Pendergrast J; Callum J; Cserti-Gazdewich C
Transfusion; 2017 Jul; 57(7):1674-1683. PubMed ID: 28369916
[TBL] [Abstract][Full Text] [Related]
14. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions.
Mourad Z; Hassab H; Younan D; Abdo A
Transfus Med; 2015 Dec; 25(6):380-4. PubMed ID: 26578338
[TBL] [Abstract][Full Text] [Related]
15. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
[TBL] [Abstract][Full Text] [Related]
16. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
Klüter H; Bubel S; Kirchner H; Wilhelm D
Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte reduction in blood component therapy.
Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE
Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of 516 reports of reactions after the transfusion of labile blood products].
Frère MC; Rapaille A; Bouillenne C; Gérard C; Sondag D; Verhees A
Transfus Clin Biol; 2001 Aug; 8(4):333-42. PubMed ID: 11642025
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of WBC reduction in neonates: what is the evidence of benefit?
Fergusson D; Hébert PC; Barrington KJ; Shapiro SH
Transfusion; 2002 Feb; 42(2):159-65. PubMed ID: 11896329
[TBL] [Abstract][Full Text] [Related]
20. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
